News Daily News Las Sociedades Recomiendan los Requisitos para el Programa TAVR L.A. McKeown March 06, 2012
Presentation TCT 2012 The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy Presenter: Paul S. Rees, Sean M. Davidson, Sian E. Harding, Perry M. Elliott, Derek J. Hausenloy, Derek M. Yellon January 03, 2012